December 6, 2016 — Calgary Scientific Inc. announced version 6.0 of their enterprise image-viewing platform ...

National Decision Support Company (NDSC) recently announced expanded CareSelect solutions that cover a wide variety of care settings and healthcare services including the ABIM Foundation's Choosing Wisely Campaign.

As part of the 2016 Radiological Society of North America (RSNA) Annual Meeting (RSNA), Philips announced the introduction of IntelliSpace Portal 9.0, the latest edition of its comprehensive, advanced visual analysis and quantification platform. Featuring a suite of multi-modality functions and expanded neurological tools, IntelliSpace Portal 9.0 helps radiologists detect, diagnose and follow up on treatment of diseases, while using new machine learning capabilities to support the physician. The solution addresses radiologists' needs for tools to better support the growing group of patients with brain injuries and neurological disorders such as dementia, strokes, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).

Materialise NV announced a pair of new partnerships for development of 3-D anatomical models with Siemens Healthineers and Carestream at the 2016 annual meeting of the Radiological Society of North America (RSNA).

New research presented at the 2016 Radiological Society of North America (RSNA) annual meeting found recall rates, cancer detection and invasive cancer detection for women under age 50 were significantly improved with the addition of tomosynthesis to mammography. The research was presented by Stephen Rose, M.D., chief medical officer of Solis Mammography and president of Rose Imaging Physicians Group, Houston.

An international group of researchers report success in mice of a method of using positron emission tomography (PET) scans to track, in real time, an antibody targeting a hormone receptor pathway specifically involved in prostate cancer. This androgen receptor pathway drives development and progression of the vast majority of prostate cancers. The technique shows promise, the investigators say, as a novel way to use such an antibody to detect and monitor prostate and other hormone-sensitive cancers, as well as to guide therapy in real time.

Boston Children's Hospital and GE Healthcare announced a collaboration to develop and commercialize digital solutions to advance the diagnosis and treatment of specific childhood diseases – starting with diseases that affect the brain. The first project, detailed at the 102nd annual meeting of the Radiological Society of North America, Nov. 27-Dec. 1 in Chicago, seeks to improve diagnostic accuracy in pediatric brain scans by providing real-time contextual information at the time and place the radiologist needs it.